7.2 mg Dose in STEP-UP Study Shows 20.7% Weight Loss in 72 Weeks
The European Medicines Agency (EMA) has signaled a shift in obesity management, validating new high-dose formulations of semaglutide—marketed as Wegovy—that demonstrate a 20.7% mean reduction in body weight over 72 ... Read More